LGALS3 and acute myeloid leukemia: Finally, the therapeutic potential of potent synthetic small-molecule Gal-3 inhibitors in human diseases is discussed, providing a reference for the application of the relevant Gal-3 inhibitor in the treatment of patients with AML, especially in patients with relapsed or refractory AML.